 |
Merck Serono, Neopharma in medicines dealGermany's Merck Serono said it would team up with an Abu Dhabi firm to produce medicines for the domestic and regional markets, the first multinational of its kind to make branded products in the UAE. More… |
 |
Merck, Sun Pharma set up generics JVHelathcare leader Merck has joined hands with India's Sun Pharmaceutical Industries to develop, manufacture and commercialise new combinations and formulations of innovative, branded generics in the emerging markets. The tieu More… |
 |
Merck's new lung drug wins FDA approvalMerck & Co's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Thursday, confirming an earlier Reuters report. The inhaled treatment has been cleared for treatin More… |
 |
Merck, Wellcome in vaccine project for poorUS drugs group Merck has teamed up with Britain's Wellcome Trust medical charity in a not-for-profit joint venture to develop affordable vaccines for poor countries. It is the first time that a drugmaker and a charity have joined forces in More… |
 |
Merck to buy Schering-Plough for $41bnMerck & Company said on Monday that it would acquire Schering-Plough Corp for $41.1 billion, uniting the makers of cholesterol drugs Zetia and Vytorin in the second megadeal for Big Pharma in weeks. The two New Jersey-based drugmakers, More… |
 |
DuBiotech, Merck discuss tie-upA high profile delegation from E. Merck OHG recently discussed potential collaborative opportunities with Dubai Biotechnology and Research Park (DuBiotech). The delegation was hosted by Dr Abdulqader Alkhayat, executive director of DuBiote More… |
Merck settles Vioxx claims for $4.85bnMerck has agreed to pay $4.85 billion to settle US claims of heart attacks and strokes allegedly linked to its withdrawn painkiller Vioxx, the drugmaker said. The agreement was reached with law firms on the steering committee for the feder More… |
Merck says FDA approves new Aids treatmentA new Aids treatment made by Merck, the first in a new class of drugs aimed at preventing replication of the virus, has been approved by US regulators, Merck said. The drug will be available in about two weeks, Merck said. The US F More… |
 |
Merck halts HIV vaccine trialsInternational drug company Merck has halted trials on an HIV vaccine that was regarded as one of the most promising in the fight against Aids. Merck stopped testing the vaccine after it was judged to be ineffective. In trials, the More… |
